In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Selected Start-Ups (4/00)

Executive Summary

In Vivo summarizes the technologies of several recently founded companies: Ardais Corp., is creating information products from consolidating high-quality, reliable biological samples and related information for use in drug discovery and development. BeneCor Heart Systems was founded in September 1999 to develop and commercialize a totally implantable, permanent heart replacement device. Chronix Biomedical will focus on the diagnosis and management of chronic diseases by detecting what it calls "reshuffled genes," the detours the human genome map takes when confronted with viruses or other toxins. Founded in July 1999 by a group of former Columbia University physicians and scientists, MediData Solutions Inc. will offer new software and technology for managing clinical trials. Spiration is developing devices to treat pulmonary diseases, in particular chronic obstructive pulmonary disease (COPD), for which no cure exists.

You may also be interested in...

Coronavirus Update: After 'Warp Speed' Snub, Novavax Awarded US Military Vaccine Deal

Progress for two US-based companies in the race to develop a COVID-19 vaccine.

Aurobindo Upbeat On Outlook, Transfers Biologics Biz

After double-digit growth in formulation sales across geographies in the fourth quarter, Aurobindo expects to continue the momentum this fiscal year. Meanwhile, it might look for partners for its biologics business, which is now transferred to its fully owned subsidiary for $48m.    

Some Annex XVI Products Likely To Be Delayed, Updated European Commission Rolling Plan Suggests

The European Commission has updated its rolling plan. It now looks as if current member state rules for non-medical products could persist beyond the 26 May 2021 deadline.

Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts